eISSN: 2353-9461
ISSN: 0860-7796
BioTechnologia
Current issue Archive About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2017
vol. 98
 
Share:
Share:
abstract:
RESEARCH PAPERS

In silico and In vitro cytotoxic effect of prodigiosin-conjugated silver nanoparticles on liver cancer cells (HepG2)

Ahmed I. El-Batal
1
,
Hoda H. El-Hendawy
2
,
Ahmed H. I. Faraag
2, 3, 4

  1. Drug Radiation Research Department, Biotechnology Division, National Center for Radiation Research and Technology (NCRRT), Atomic Energy Authority, Cairo, Egypt
  2. Botany and Microbiology Department, Faculty of Science, Helwan University, Cairo, Egypt
  3. Bioinformatics Center, Faculty of Science, Helwan University, Cairo, Egypt
  4. Nanotechnology Center, Helwan University, Cairo, Egypt
BioTechnologia vol. 98(3) C pp. 225-243 C 2017
Online publish date: 2018/01/02
View full text Get citation
 
PlumX metrics:
This study demonstrates a novel approach for the synthesis of silver nanoparticles (AgNPs) against human liver cancer cell line (HepG2) using prodigiosin pigment isolated from Serratia marcescens. It further investigates the influence of various parameters such as initial pH, temperature, silver nitrate (AgNO3) concentration, and prodigiosin concentration on stability and optical properties of synthesized prodigiosin AgNPs. Highly stable, spherical prodigiosin-conjugated AgNPs were synthesized with a mean diameter of 9.98 nm using a rapid one-step method. The cytotoxic activity investigated in the present study indicated that prodigiosin and prodigiosin-conjugated AgNPs possessed a strong cytotoxic potency against human liver cancer. The In silico molecular docking results of prodigiosin and prodigiosin-conjugated AgNPs are congruent with the In vitro studies and these AgNPs can be considered as good inhibitors of mitogen-activated protein kinase 1 (MEK kinases). The study opened the possibility of using prodigiosin-conjugated AgNPs to increase the efficiency of liver cancer treatment.
keywords:

silver nanoparticles, cytotoxic activity, Serratia marcescens, In silico, prodigiosin



Stosujemy się do standardu HONcode dla wiarygodnej informacji zdrowotnej This site complies with the HONcode standard for trustworthy health information: verify here